Point-Of-Care Diabetes Test Gains FDA Panel Endorsement As Diagnostic
Executive Summary
Members of US FDA's Clinical Chemistry and Toxicology Device Panel say Alere’s Afinion HbA1c Dx is safe and effective for the diagnosis of diabetes in settings such as larger physician office labs, but were worried about the company’s plan to eventually expand the test’s use to community events.